# Keryx Biopharmaceuticals

Organization · id `cardio:org-keryx-biopharmaceuticals` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Keryx+Biopharmaceuticals>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Keryx Biopharmaceuticals
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease (`cardio:ct-nct01074125`)
- Sponsors: A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis (`cardio:ct-nct01191255`)
- Sponsors: A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis (`cardio:ct-nct01554982`)
- Sponsors: Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis (`cardio:ct-nct01736397`)
- Sponsors: KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD (`cardio:ct-nct02268994`)
- Sponsors: Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D (`cardio:ct-nct02492620`)
- Sponsors: KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial) (`cardio:ct-nct03236246`)

## Provenance

Content hash: 2dec0fd5beb25d598f89aa5d4bd00bc522c67f76a2aabba67b193099438f9590
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
